MedTrace Logo

Tobacco Intervention in Primary Care Treatment Opportunities for Providers

NCT02096029 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1278

Last updated 2019-08-07

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to evaluate the use of "sampling" of smoking cessation medications (nicotine patches and lozenges) among smokers seen in primary care settings. Half of study participants will be provided with samples of medication, to use however they wish; the other half will not be provided with these samples. All smokers will be advised to quit through routine contact with their physician. After the primary care contact, all participants will be contacted by phone for three brief follow-up interviews, which will involve answering questionnaires about their smoking habits.

Conditions

  • Smoking
  • Smoking Cessation

Interventions

OTHER

Nicotine Replacement Therapy (NRT) Sampling

2 week supply of 4 mg nicotine lozenge and 14 mg nicotine patch

BEHAVIORAL

Ask, Advise, Refer (physician brief advice)

Sponsors & Collaborators

  • National Institute on Drug Abuse (NIDA)

    collaborator NIH

  • Medical University of South Carolina

    lead OTHER

Principal Investigators

  • Matthew J Carpenter, PhD · Medical University of South Carolina

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-07-31
Primary Completion
2018-06-15
Completion
2018-06-15

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02096029 on ClinicalTrials.gov